Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiopharmaceuticals
Biotech
Regeneron rides into radiopharma via $2.1B biobucks Telix pact
With its latest obesity play appearing to pay off, Regeneron has turned its attention to radiopharmaceuticals.
James Waldron
Apr 13, 2026 7:24am
Fierce Pharma
Novartis pledges nearly $480M to bolster China production, R&D
Mar 23, 2026 10:35am
AstraZeneca vows $15B China investment to boost R&D capabilities
Jan 29, 2026 5:50am
Radiopharma-focused Aktis bring in $318M via upsized IPO
Jan 9, 2026 4:52am
Fierce Pharma
3 biopharma CEOs explain why they are 'authentically optimistic'
Jan 6, 2026 11:54am
Aktis aims for $209M windfall from 1st biotech IPO of 2026
Jan 5, 2026 9:30am
